ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.38p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 11.13
  • 52 Week Low: 3.38
  • Currency: UK Pounds
  • Shares Issued: 57.17m
  • Volume: 0
  • Market Cap: £1.93m
  • RiskGrade: 394

ReNeuron Group Overview

ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.
Registrars: Computershare Investor Services PLC

Key Personnel

Chief Finance Officer: John Hawkins
Executive Chairman: Iain G Ross
Independent Non-Executive Director: Martin Walton
Independent Non-Executive Director: Mike Owen
Senior Independent Non-Executive Director: Barbara Staehelin
Non-Executive Dir:

Contact Details

Address: Pencoed Business Park, Pencoed, Bridgend, United Kingdom, CF35 5HY
Phone: +44 (0) 203 819 8400
Fax: +44 (0)14 8353 4864
Website: http://www.reneuron.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF5G6K95

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 3.38p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 11.13
52 Week Low 3.38
Volume 0
Shares Issued 57.17m
Market Cap £1.93m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.89% above the market average68.89% above the market average68.89% above the market average68.89% above the market average68.89% above the market average
5.66% above the sector average5.66% above the sector average5.66% above the sector average5.66% above the sector average5.66% above the sector average
Price Trend
89.79% below the market average89.79% below the market average89.79% below the market average89.79% below the market average89.79% below the market average
54.39% below the sector average54.39% below the sector average54.39% below the sector average54.39% below the sector average54.39% below the sector average
Income Not Available
Growth
6.31% above the market average6.31% above the market average6.31% above the market average6.31% above the market average6.31% above the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page